Effects of ε-Aminocaproic Acid and Aprotinin on Leukocyte-Platelet Adhesion in Patients Undergoing Cardiac Surgery

Anesthesiology

Volumn 100, Issue 2, 2004, Pages 225-233

  Greilich, Philip E ^a,c   Brouse, Chad F ^a   Rinder, Christine S ^b   Smith, Brian R ^b   Sandoval, Bernardo A ^a   Rinder, Henry M ^b   Eberhart, Robert C ^a   Jessen, Michael E ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b YALE UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMINOCAPROIC ACID; ANTIARRHYTHMIC AGENT; ANTIFIBRINOLYTIC AGENT; APROTININ; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; D DIMER; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FENTANYL; HEPARIN; ISOFLURANE; PLASMIN; PROPOFOL; STATINE; SERINE PROTEINASE INHIBITOR;

ARTICLE; CARDIOPULMONARY BYPASS; CELL INTERACTION; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONJUGATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; LEUKOCYTE ADHERENCE; MALE; MONOCYTE; NEUTROPHIL; PATIENT MONITORING; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RANDOMIZATION; SURGICAL PATIENT; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; AGED; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; DOUBLE BLIND PROCEDURE; LEUKOCYTE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE ADHESIVENESS;

6-AMINOCAPROIC ACID; AGED; ANTIFIBRINOLYTIC AGENTS; APROTININ; CORONARY ARTERY BYPASS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; PLATELET ADHESIVENESS; SERINE PROTEINASE INHIBITORS;

EID: 1442290404     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200402000-00008     Document Type: Article

References (39)

1. Rinder CS, Bonan JL, Rinder HM, Mathew J, Hines R, Smith BR: Cardiopulmonary bypass induces leukocyte-platelet adhesion. Blood 1992; 79:1201-5
2. Rinder C, Fitch J: Amplification of the inflammatory response: Adhesion molecules associated with platelet/white cell responses. J Cardiovasc Pharmacol 1996; 27:S6-12
3. McEver RP: Properties of GMP-140, and inducible granule membrane protein of platelets and endothelium. Blood Cells 1990; 16:73-83
4. Arnaout AM: Structure and function of the leukocyte adhesion molecules CD11/CD18. Blood 1990; 75:1037-50
5. Mazzone A, De Servi S, Ricevuti G, Mazzucchclli I, Fossati G, Pasotti D, Bramucci E, Angoli L, Marsico F, Specchia G: Increased expression of neutrophil and monocyte adhesion molecules in unstable coronary, artery disease. Circulation 1993; 88:358-63
6. Rinder HM, Bonan JL, Rinder CS, Ault KA, Smith BR: Dynamics of leukocyte, platelet adhesion in whole blood. Blood 1991; 78:1730-7
7. Evangelista V, Manarini S, Sideri R, Rotondo S, Martelli N, Piccoli A, Totani L, Piccardoni P, Vestweber D, de Gaetano G, Cerletti C: Platelet/polymorphonuclear leukocyte interaction: P-selectin triggers protein-tyrosine phosphorylation-dependent CD11b/CD18 adhesion: Role of PSGL-1 as a signaling molecule. Blood 1999; 93:876-85
8. Pratico D, Iuliano L, Alessandri C, Camastra C, Violi F: Polymorphonuclear leukocyte-derived O2-reactive species activate primed platelets in human whole blood. Am J Physiol 1993; 264:H1582-7
9. Li N, Hu H, Lindqvist M, Wikstrom-Jonsson E, Goodall AH, Hjemdahl P: Platelet-leukocyte cross talk in whole blood. Arterioscler Thromb Vasc Biol 2000; 20:2702-8
10. Neumann FJ, Marx N, Gawaz M, Brand K, Ott I, Rokitta C, Sticherling C, Meinl C, May A, Schomig A: Induction of cytokine expression in leukocytes by binding of thrombin-stimulated platelets. Circulation 1997; 95:2387-94
11. Weyrich AS, Elstad MR, McEver RP, McIntyre TM, Moore KL, Morrissey JH, Prescott SM, Zimmerman GA: Activated platelets signal chemokine synthesis by human monocytes. J Clin Invest 1996; 97:1525-34
12. Maugeri N, Evangelista V, Piccardoni P, Dell'Elba G, Celardo A, de Gaetano G, Cerletti C: Transcellular metabolism of arachidonic acid: Increased platelet thromboxane generation in the presence of activated polymorphonuclear leukocytes. Blood 1992; 80:447-51
13. Freedman JE, Loscalzo J: Platelet-monocyte aggregates: Bridging thrombosis and inflammation. Circulation 2002; 105:2130-2
14. Furman MI, Barnard MR, Krueger LA, Fox ML, Shilale EA, Lessard DM, Marchese P, Frelinger AL III, Goldberg RJ, Michelson AD: Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction. J Am Coll Cardiol 2001; 38:1002-6
15. Mojcik CE, Levy JH: Aprotinin and the systemic inflammatory response after cardiopulmonary bypass. Ann Thorac Surg 2001; 71:745-54
16. Laffey JG, Boylan JF, Cheng DC: The systemic inflammatory response to cardiac surgery: Implications for the anesthesiologist. Anesthesiology 2002; 97:215-52
17. de Haan J, van Oeveren W: Platelets and soluble fibrin promote plasminogen activation causing downregulation of platelet glycoprotein Ib/IX complexes: Protection by aprotinin. Thromb Res 1998; 92:171-9
18. Ray MJ, Marsh NA: Aprotinin reduces blood loss after cardiopulmonary bypass by direct inhibition of plasmin. Thromb Haemost 1997; 78:1021-6
19. Verstraete M: Clinical application of inhibitors of fibrinolysis. Drugs 1985; 29:236-61
20. Syrovets T, Jendrach M, Rohwedder A, Schule A, Simmet T: Plasmin-induced expression of cytokines and tissue factor in human monocytes involves AP-1 and IKKβ-mediated NF-κB activation. Blood 2001; 97:3941-50
21. Ryan TJ, Lai L, Malik AB: Plasmin generation induces neutrophil aggregation: Dependence on the catalytic and lysine binding sites. J Cell Physiol 1992; 151:255-61
22. Michelson AD, Barnard MR, Krueger LA, Valeri CR, Furman MI: Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: Studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation 2001; 104:1533-7
23. Inui K, Shimazaki Y, Watanabe T, Kuraoka S, Uesho K, Uchida T, Shiono S: Aprotinin reduces the expression of p-selectin on the surface of platelet and leukocyte-platelet conjugates. Artif Organs 1998; 22:1018-22
24. Wahba A, Black G, Koksch M, Rothe G, Preuner J, Schmitz G, Birnbaum DE: Aprotinin has no effect on platelet activation and adhesion during cardiopulmonary bypass. Thromb Haemost 1996; 75:844-8
25. Ray MJ, Marsh NA, Just SJ, Perrin EJ, O'Brien MF, Hawson GA: Preoperative platelet dysfunction increases the benefit of aprotinin in cardiopulmonary bypass. Ann Thorac Surg 1997; 63:57-63
26. Kozek-Langenecker SA, Mohammad SF, Masaki T, Green W, Kamerath C, Cheung AK: The effects of aprotonin on platelets in vitro using whole blood flow cytometry. Anesth Analg 2000; 90:12-6
27. Rinder CS, Rinder HM, Johnson K, Smith M, Lee DL, Tracey J, Polack G, Higgins P, Yeh CG, Smith BR: Role of C3 cleavage in monocyte activation during extracorporeal circulation. Circulation 1999; 100:553-8
28. Rinder CS, Rinder HM, Smith MJ, Tracey JB, Fitch J, Li L, Rollins SA, Smith BR: Selective blockade of membrane attack complex formation during simulated extracorporeal circulation inhibits platelet but not leukocyte activation. J Thorac Cardiovasc Surg 1999; 118:460-6
29. Davenpeck KL, Brummet ME, Hudson SA, Mayer RJ, Bochner BSi Activation of human leukocytes reduces surface P-selectin glycoprotein ligand-1 (PSGL-1, CD162) and adhesion to P-selectin in vitro. J Immunol 2000; 165:2764-72
30. Gardiner EE, De Luca M, McNally T, Michelson AD, Andrews RK, Berndt MC: Regulation of P-selectin binding to the neutrophil P-selectin counter-receptor P-selectin glycoprotein ligand-1 by neutrophil elastase and cathepsin G. Blood 2001; 98:1440-7
31. Asimakopoulos G, Kohn A, Stefanou DC, Haskard DO, Landis RC, Taylor KM: Leukocyte integrin expression in patients undergoing cardiopulmonary bypass. Ann Thorac Surg 2000; 69:1192-7
32. Kupatt C, Habazettl H, Zahler S, Weber C, Becker BF, Messmer K, Gerlach E: ACE-inhibition prevents postischemic coronary leukocyte adhesion and leukocyte-dependent reperfusion injury. Cardiovasc Res 1997; 36:386-95
33. Lefer AM, Campbell B, Shin YK, Scalia R, Hayward R, Lefer DJ: Simvastatin preserves the ischemic-reperfused myocardium in normocholesterolemic rat hearts. Circulation 1999; 100:178-84
34. Koster A, Fischer T, Praus M, Haberzettl H, Kuebler WM, Hetzer R, Kuppe H: Hemostatic activation and inflammatory response during cardiopulmonary bypass: Impact of heparin management. ANESTHESIOLOGY 2002; 97:837-41
35. Ray MJ, Hales M, Marsh N: Epsilon-aminocaproic acid promotes the release of alpha2-antiplasmin during and after cardiopulmonary bypass. Blood Coagul Fibrinolysis 2001; 12:129-35
36. Herren T, Burke TA, Jardi M, Felez J, Plow EF: Regulation of plasminogen binding to neutrophils. Blood 2001; 97:1070-8
37. Faraday N, Scharpf RB, Dodd-o JM, Martinez EA, Rosenfeld BA, Dorman T: Leukocytes can enhance platelet-mediated aggregation and thromboxane release via interaction of P-selectin glycoprotein ligand 1 with P-selectin. ANESTHESIOLOGY 2001; 94:145-51
38. Nagata K, Tsuji T, Todoroki N, Katagiri Y, Tanoue K, Yamazaki H, Hanai N, Irimura T: Activated platelets induce superoxide anion release by monocytes and neutrophils through P-selectin (CD62). J Immunol 1993; 151:3267-73
39. Weyrich AS, McIntyre TM, McEver RP, Prescott SM, Zimmerman GA: Monocyte tethering by P-selectin regulates monocyte chemotactic protein-1 and tumor necrosis factor-alpha secretion: Signal integration and NF-kappa B translocation. J Clin Invest 1995; 95:2297-303